You are being redirected to the story the piece of content is found in so you can read it in context. Please click the following link if you are not automatically redirected within a couple seconds:

[PDF] Branding the Cure: A consumer perspective on Corporate Social Responsibility, Drug Promotion and the Pharmaceutical Industry

Author: Consumers International, Published on: 1 June 2006

Main findings: Limited transparency in reporting CSR information...New marketing tactics may not be to consumers’ benefit...Breaches of regulations and CSR codes occur with regular frequency showing weak industry self-regulation...Strong and effective CSR must support [the following rights:] the right to safety [,] the right to be informed [,] the right to satisfaction of basic needs [,] the right to education [,] the right to a healthy environment. [The companies studied included: Abbott, AstraZeneca, Almirall Prodesfarma, Bayer, Boehringer-Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Johnson & Johnson (J&J), Lilly (Eli), Lundbeck, Menarini, Merck Sharp Dohme, Novartis, Novo Nordisk [part of Novo Group], Nycomed, Orion Pharma, Pfizer, Roche, Sanofi-Aventi, Schering AG, Schering-Plough, Wyeth]

Read the full post here

Related companies: Abbott Laboratories Almirall Prodesfarma AstraZeneca Bayer Boehringer Ingelheim Bristol-Myers Squibb Eli Lilly GlaxoSmithKline Johnson & Johnson Lundbeck Menarini Merck Merck Sharp & Dohme (part of Merck) Novartis Novo Group Novo Nordisk (part of Novo Group) Nycomed Orion Pfizer Roche Sanofi Schering-Plough Wyeth (part of Pfizer)